Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Eli Lilly | NYSE | Healthcare | Pharmaceuticals | $811.57B | 39.4x | 0.42 | $905.03 | -1.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 36.6% Upside | Upgrade to Pro+ | |
| J&J | NYSE | Healthcare | Pharmaceuticals | $578.31B | 27.3x | -7.06 | $238.67 | -0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 6.7% Upside | Upgrade to Pro+ | |
| AbbVie | NYSE | Healthcare | Pharmaceuticals | $368.98B | 88.3x | -70.78 | $208.42 | -0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 18.4% Upside | Upgrade to Pro+ | |
| Roche Holding ADR | OTC Markets | Healthcare | Pharmaceuticals | $335.94B | 19.8x | 0.36 | $50.99 | -0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 10% Upside | Upgrade to Pro+ | |
| AstraZeneca | NYSE | Healthcare | Pharmaceuticals | $310.55B | 30.6x | 0.68 | $201.21 | -1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 8.1% Upside | Upgrade to Pro+ | |
| Merck&Co | NYSE | Healthcare | Pharmaceuticals | $292.04B | 16.2x | 2.02 | $117.90 | -1.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 14.2% Upside | Upgrade to Pro+ | |
| Novartis | OTC Markets | Healthcare | Pharmaceuticals | $288.99B | 21.3x | 0.96 | $146.25 | -6.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| Novartis ADR | NYSE | Healthcare | Pharmaceuticals | $288.99B | 21.3x | 0.96 | $152.08 | -0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -1.2% Downside | Upgrade to Pro+ | |
| UnitedHealth | NYSE | Healthcare | Healthcare Providers & Services | $285.59B | 23.8x | -1.61 | $314.05 | -0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 13.2% Upside | Upgrade to Pro+ | |
| Thermo Fisher Scientific | NYSE | Healthcare | Healthcare Equipment & Supplies | $197.58B | 30x | 3.99 | $531.67 | 0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 23.1% Upside | Upgrade to Pro+ | |
| Amgen | NASDAQ | Healthcare | Pharmaceuticals | $188.03B | 24.2x | 0.28 | $348.22 | -0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 0% Upside | Upgrade to Pro+ | |
| Abbott Labs | NYSE | Healthcare | Healthcare Equipment & Supplies | $176.55B | 27.4x | -0.53 | $101.56 | 0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 29.6% Upside | Upgrade to Pro+ | |
| Novo Nordisk ADR | NYSE | Healthcare | Pharmaceuticals | $176.43B | 11x | 6.03 | $40.81 | 3.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 14.5% Upside | Upgrade to Pro+ | |
| Gilead | NASDAQ | Healthcare | Pharmaceuticals | $173.49B | 20.4x | 0.01 | $139.77 | -0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 15.7% Upside | Upgrade to Pro+ | |
| Intuitive Surgical | NASDAQ | Healthcare | Healthcare Equipment & Supplies | $166.35B | 58.6x | 2.59 | $468.36 | 0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 30.9% Upside | Upgrade to Pro+ | |
| Pfizer | NYSE | Healthcare | Pharmaceuticals | $154.89B | 19.9x | -5.94 | $27.19 | 0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 0.8% Upside | Upgrade to Pro+ | |
| Danaher | NYSE | Healthcare | Healthcare Equipment & Supplies | $140.01B | 39.5x | -8.59 | $198.14 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 34.7% Upside | Upgrade to Pro+ | |
| Stryker | NYSE | Healthcare | Healthcare Equipment & Supplies | $130.95B | 40.4x | 4.97 | $341.24 | -1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 21.4% Upside | Upgrade to Pro+ | |
| Bristol-Myers Squibb | NYSE | Healthcare | Pharmaceuticals | $118.20B | 16.6x | 0.09 | $57.89 | -0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 10.9% Upside | Upgrade to Pro+ | |
| Sanofi ADR | NASDAQ | Healthcare | Pharmaceuticals | $115.64B | 20.2x | 0.45 | $48.02 | 0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 18.7% Upside | Upgrade to Pro+ | |
| GSK plc | OTC Markets | Healthcare | Pharmaceuticals | $115.53B | 15.2x | 0.12 | $29.24 | -0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| GSK plc DRC | NYSE | Healthcare | Pharmaceuticals | $115.53B | 15.2x | 0.12 | $57.81 | -2.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -5.4% Downside | Upgrade to Pro+ | |
| Vertex | NASDAQ | Healthcare | Pharmaceuticals | $112.35B | 28.9x | 0.03 | $441.70 | -0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 26.3% Upside | Upgrade to Pro+ | |
| Medtronic | NYSE | Healthcare | Healthcare Equipment & Supplies | $111.62B | 24.5x | 2.59 | $87.10 | -1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 24.8% Upside | Upgrade to Pro+ | |
| Essilor International SA | OTC Markets | Healthcare | Healthcare Equipment & Supplies | $111.45B | 41.2x | -13.96 | $120.51 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| HCA | NYSE | Healthcare | Healthcare Providers & Services | $109.23B | 17x | 0.57 | $488.58 | -2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 13.5% Upside | Upgrade to Pro+ | |
| McKesson | NYSE | Healthcare | Pharmaceuticals | $105.71B | 24.8x | 0.41 | $863.42 | 0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 15.9% Upside | Upgrade to Pro+ | |
| CVS Health Corp | NYSE | Healthcare | Healthcare Providers & Services | $96.11B | 54.2x | -0.91 | $74.99 | -3.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 28% Upside | Upgrade to Pro+ | |
| Boston Scientific | NYSE | Healthcare | Healthcare Equipment & Supplies | $95.90B | 33.2x | 0.59 | $64.61 | 1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| Chugai Pharma ADR | OTC Markets | Healthcare | Pharmaceuticals | $89.82B | 32.8x | 2.67 | $27.13 | 0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| Regeneron Pharma | NASDAQ | Healthcare | Pharmaceuticals | $77.53B | 18.1x | 2.1 | $753.93 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 16.1% Upside | Upgrade to Pro+ | |
| Cigna | NYSE | Healthcare | Healthcare Providers & Services | $71.87B | 12.1x | 0.15 | $268.63 | -1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 25.1% Upside | Upgrade to Pro+ | |
| Elevance Health | NYSE | Healthcare | Healthcare Providers & Services | $68.36B | 12.3x | -6.64 | $311.18 | -0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 22.5% Upside | Upgrade to Pro+ | |
| Hoya Corp | OTC Markets | Healthcare | Healthcare Equipment & Supplies | $62.97B | 40.7x | 1.71 | $190.18 | 1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 7.6% Upside | Upgrade to Pro+ | |
| Medline | NASDAQ | Healthcare | Healthcare Equipment & Supplies | $62.62B | 30x | 0.02 | $47.93 | 0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 15% Upside | Upgrade to Pro+ | |
| Cencora Inc | NYSE | Healthcare | Healthcare Equipment & Supplies | $61.71B | 38.2x | 2.05 | $317.58 | -0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 27.4% Upside | Upgrade to Pro+ | |
| Merck ADR | OTC Markets | Healthcare | Pharmaceuticals | $60.11B | 19.5x | -3.18 | $27.62 | 0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 23.7% Upside | Upgrade to Pro+ | |
| UCB ADR | OTC Markets | Healthcare | Pharmaceuticals | $59.71B | 32.5x | 0.71 | $156.57 | -1.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 7.9% Upside | Upgrade to Pro+ | |
| Takeda Pharma ADR | NYSE | Healthcare | Pharmaceuticals | $56.88B | 80.3x | -1.71 | $17.85 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 18.6% Upside | Upgrade to Pro+ | |
| Takeda Pharma | OTC Markets | Healthcare | Pharmaceuticals | $56.85B | 80.3x | -1.73 | $34.52 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
| argenx ADR | NASDAQ | Healthcare | Biotechnology & Medical Research | $52.10B | 40x | 0.74 | $840.87 | 1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 23.4% Upside | Upgrade to Pro+ | |
| Zoetis Inc | NYSE | Healthcare | Pharmaceuticals | $50.70B | 20.1x | 1.89 | $120.76 | -0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 20.1% Upside | Upgrade to Pro+ | |
| Siemens Healthineers ADR | OTC Markets | Healthcare | Healthcare Equipment & Supplies | $50.49B | 21.9x | 2.86 | $22.55 | 0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 42.3% Upside | Upgrade to Pro+ | |
| Cardinal Health | NYSE | Healthcare | Pharmaceuticals | $49.85B | 30.4x | 1.04 | $211.83 | -1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 20.4% Upside | Upgrade to Pro+ | |
| Lonza Group AG | OTC Markets | Healthcare | Biotechnology & Medical Research | $47.72B | 39.5x | -0.28 | $68.14 | 0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 19.2% Upside | Upgrade to Pro+ | |
| CSL | OTC Markets | Healthcare | Pharmaceuticals | $47.63B | 34.4x | -0.68 | $25.40 | 2.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 29% Upside | Upgrade to Pro+ | |
| Bayer AG PK | OTC Markets | Healthcare | Pharmaceuticals | $47.34B | -11.1x | 0.26 | $11.96 | 0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 24.4% Upside | Upgrade to Pro+ | |
| IDEXX Labs | NASDAQ | Healthcare | Healthcare Equipment & Supplies | $46.03B | 44.5x | 1.94 | $580.76 | -0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 32.7% Upside | Upgrade to Pro+ | |
| Edwards Lifesciences | NYSE | Healthcare | Healthcare Equipment & Supplies | $45.05B | 43.3x | -0.58 | $78.20 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 26.2% Upside | Upgrade to Pro+ | |
| Becton Dickinson | NYSE | Healthcare | Healthcare Equipment & Supplies | $44.26B | 25.5x | 8.16 | $155.52 | -0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 22.4% Upside | Upgrade to Pro+ |